Cargando…
Postoperative circulating tumor DNA can refine risk stratification in resectable lung cancer: results from a multicenter study
Circulating tumor DNA (ctDNA) has potential as a promising biomarker for molecular residual disease (MRD) detection in lung cancer. As the next‐generation sequencing standardized panel for ctDNA detection emerges, its clinical utility needs to be validated. We prospectively recruited 184 resectable...
Autores principales: | Fu, Rui, Huang, Jun, Tian, Xiaoru, Liang, Chaoyang, Xiong, Yuanyuan, Zhang, Jia‐Tao, Jiang, Benyuan, Dong, Song, Gong, Yuhua, Gao, Wei, Li, Fang, Shi, Yonglei, Liu, Zhentian, Gao, Xuan, Chen, Rongrong, Zhong, Wenzhao, Zhang, Yi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10158775/ https://www.ncbi.nlm.nih.gov/pubmed/36732646 http://dx.doi.org/10.1002/1878-0261.13387 |
Ejemplares similares
-
A Novel Comprehensive Clinical Stratification Model to Refine Prognosis of Glioblastoma Patients Undergoing Surgical Resection
por: Ius, Tamara, et al.
Publicado: (2020) -
Improving on-treatment risk stratification of cancer patients with refined response classification and integration of circulating tumor DNA kinetics
por: Lv, Jiawei, et al.
Publicado: (2022) -
Risk Stratification in Lung Resection
por: Salati, Michele, et al.
Publicado: (2016) -
Prognostic, predictive, and pharmacogenomic assessments of CDX2 refine stratification of colorectal cancer
por: Bruun, Jarle, et al.
Publicado: (2018) -
Three-dimensional computed tomography reconstruction in video-assisted thoracoscopic segmentectomy (DRIVATS): A prospective, multicenter randomized controlled trial
por: Niu, Zhenyi, et al.
Publicado: (2022)